The Genetics of Congestive Heart Failure

Heart Failure Clinics

Volumn 6, Issue 2, 2010, Pages 223-230

  MacRae, Calum A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cardiomyopathies; Congestive heart failure; Genome wide association studies; Mendelian cardiomyopathy genetics

Indexed keywords

CALCINEURIN; GHRELIN; LEPTIN; NATRIURETIC FACTOR; NEUROHORMONE; PARATHYROID HORMONE;

CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CYTOLOGY; ELECTROCARDIOGRAM; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENETIC ENGINEERING AND GENE TECHNOLOGY; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE MAP; HEART LEFT VENTRICLE FUNCTION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; MOLECULAR CLONING; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; TISSUE DOPPLER IMAGING;

CARDIOMYOPATHIES; GENOME-WIDE ASSOCIATION STUDY; HEART FAILURE; HUMANS; PHENOTYPE; RISK FACTORS; SYNDROME;

EID: 77949909542     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2009.11.004     Document Type: Review

References (55)

1. Mann D.L., and Bristow M.R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111 21 (2005) 2837-2849
2. Seidman J.G., and Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 4 (2001) 557-567
3. Parmacek M.S., and Epstein J.A. Pursuing cardiac progenitors: regeneration redux. Cell 120 3 (2005) 295-298
4. Pfeffer J.M., Pfeffer M.A., Fletcher P.J., et al. Progressive ventricular remodeling in rat with myocardial infarction. Am J Phys 260 5 Pt 2 (1991) H1406-H1414
5. Schmitt J.P., Kamisago M., Asahi M., et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299 5611 (2003) 1410-1413
6. Berridge M.J., Bootman M.D., and Roderick H.L. Calcium signaling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4 7 (2003) 517-529
7. Molkentin J.D. Dichotomy of Ca2+ in the heart: contraction versus intracellular signaling. J Clin Invest 116 3 (2006) 623-626
8. Mehra M.R., Uber P.A., and Potluri S. Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts. Am J Med Sci 324 5 (2002) 267-275
9. Teerlink J.R. Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy?. J Card Fail 8 3 (2002) 124-127
10. Arnlov J., and Vasan R.S. Neurohormonal activation in populations susceptible to heart failure. Heart Fail Clin 1 1 (2005) 11-23
11. Tang W.H., and Francis G.S. Neurohormonal upregulation in heart failure. Heart Fail Clin 1 1 (2005) 1-9
12. Balmain S., Padmanabhan N., Ferrell W.R., et al. Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function. Eur J Heart Fail 9 9 (2007) 865-871
13. Heywood J.T. The cardiorenal syndrome: lessons from the ADHERE database and treatment options. Heart Fail Rev 9 3 (2004) 195-201
14. Bongartz L.G., Cramer M.J., Doevendans P.A., et al. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 26 1 (2005) 11-17
15. Ronco C., Cruz D.N., and Ronco F. Cardiorenal syndromes. Curr Opin Crit Care (2009)
16. Delgado J.F., Conde E., Sanchez V., et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail 7 6 (2005) 1011-1016
17. Molkentin J.D., and Robbins J. With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol 46 2 (2009) 130-136
18. Baig M.K., Goldman J.H., Caforio A.L., et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 31 1 (1998) 195-201
19. Mahon N.G., Murphy R.T., MacRae C.A., et al. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med 143 2 (2005) 108-115
20. Wagner K.D., Wagner N., Ghanbarian H., et al. RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse. Dev Cell 14 6 (2008) 962-969
21. Divakaran V., and Mann D.L. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103 10 (2008) 1072-1083
22. Ellinor P.T., Low A.F., and Macrae C.A. Reduced apelin levels in lone atrial fibrillation. Eur Heart J 27 2 (2006) 222-226
23. Gudbjartsson D.F., Arnar D.O., Helgadottir A., et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007)
24. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107 23 (2003) 2920-2925
25. Keating M.T., and Sanguinetti M.C. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104 4 (2001) 569-580
26. Lander E.S., and Schork N.J. Genetic dissection of complex traits. Science 265 5181 (1994) 2037-2048
27. Risch N.J. Searching for genetic determinants in the new millennium. Nature 405 6788 (2000) 847-856
28. Arking D.E., Pfeufer A., Post W., et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38 6 (2006) 644-651
29. Vasan R.S., Glaze N.L., Felix J.F., et al. Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA 302 (2009) 168-178
30. Newton-Cheh C., Larson M.G., Vasan R.S., et al. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 41 3 (2009) 348-353
31. Gerszten R.E., and Wang T.J. Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol Lung Cell Mol Physiol 295 1 (2008) L16-L22
32. Freimer N., and Sabatti C. The human phenome project. Nat Genet 34 1 (2003) 15-21
33. Cannon T.D. The inheritance of intermediate phenotypes for schizophrenia. Curr Opin Psychiatry 18 2 (2005) 135-140
34. Garver D.L., Holcomb J.A., and Christensen J.D. Heterogeneity of response to antipsychotics from multiple disorders in the schizophrenia spectrum. J Clin Psychiatry 61 12 (2000) 964-972 [quiz: 973]
35. Rual J.F., Ceron J., Koreth J., et al. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res 14 10B (2004) 2162-2168
36. Gabriel S.B., Salomon R., Pelet A., et al. Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat Genet 31 1 (2002) 89-93
37. Ellinor P.T., Yoerger D.M., Ruskin J.N., et al. Familial aggregation in lone atrial fibrillation. Hum Genet 118 2 (2005) 179-184
38. Franco D., and Campione M. The role of Pitx2 during cardiac development. Linking left-right signaling and congenital heart diseases. Trends Cardiovasc Med 13 4 (2003) 157-163
39. Singer E. "Phenome" project set to pin down subgroups of autism. Nat Med 11 6 (2005) 583
40. Roden D.M., and George Jr. A.L. The genetic basis of variability in drug responses. Nat Rev Drug Discov 1 1 (2002) 37-44
41. Lin M., Aquinlante C., Johnson J.A., et al. Sequencing drug response with HapMap. Pharmacogenomics J 5 3 (2005) 149-156
42. Allessie M.A., Boyden P.A., Camm A.J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation 103 5 (2001) 769-777
43. Antzelevitch C., and Fish J. Electrical heterogeneity within the ventricular wall. Basic Res Cardiol 96 6 (2001) 517-527
44. Ho C.Y., Sweitzer N.K., McDonough B., et al. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105 25 (2002) 2992-2997
45. Shaw S.Y., Westly E.C., Pitter M.J., et al. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci U S A 105 21 (2008) 7387-7392
46. Lewis G.D., Asnani A., Gerszten R.E., et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 118 10 (2008) 3503-3512
47. Walhout A.J., Reboul J., Shtanko O., et al. Integrating interactome, phenome, and transcriptome mapping data for the C. elegans germline. Curr Biol 12 22 (2002) 1952-1958
48. Plaster N.M., Tawil R., Tristani-Firouzi M., et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105 4 (2001) 511-519
49. Splawski I., Timothy K.W., Sharpe L.M., et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119 1 (2004) 19-31
50. Li S., Armstrong C.M., Bertin N., et al. A map of the interactome network of the metazoan C. elegans. Science 303 5657 (2004) 540-543
51. Tong A.H., Lesage G., Bader G.D., et al. Global mapping of the yeast genetic interaction network. Science 303 5659 (2004) 808-813
52. Rual J.F., Venkatesan K., Hao T., et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437 7062 (2005) 1173-1178
53. Joyce A.R., and Palsson B.O. The model organism as a system: integrating 'omics' data sets. Nat Rev Mol Cell Biol 7 3 (2006) 198-210
54. Schadt E.E., Lamb J., Yang X., et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 37 7 (2005) 710-717
55. Lusis A.J. Genetic factors in cardiovascular disease. 10 questions. Trends Cardiovasc Med 13 8 (2003) 309-316